Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status

BACKGROUND: Analysis of deficiency in DNA mismatch repair (dMMR) is currently considered a standard molecular test in all patients with colorectal cancer (CRC) for its implications in screening, prognosis and prediction of benefit from immune checkpoint inhibitors. While the molecular heterogeneity...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Loupakis, Fotios, Maddalena, Giulia, Depetris, Ilaria, Murgioni, Sabina, Bergamo, Francesca, Dei Tos, Angelo Paolo, Rugge, Massimo, Munari, Giada, Nguyen, Andrew, Szeto, Christopher, Zagonel, Vittorina, Lonardi, Sara, Fassan, Matteo
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842181/
https://ncbi.nlm.nih.gov/pubmed/31703605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0788-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker